Wednesday 16 September 2026

One To Watch

AOP Orphan

Company Overview

Want to Update your Company's Profile?


Latest AOP Orphan News

AOP Orphan brings Thromboreductin to Russian market
4 November 2014
Cardiome out-licenses Aggrastat in select European markets
20 May 2014
Planned expansion of anti-psychotic drug throughout Europe
29 October 2013
Cardiome signs deal with AOP Orphan to market CAF drug Brinavess
4 July 2013
More AOP Orphan news >


Today's issue

Vivan and Ad Atomica pair tumor genotype data with AI drug design
Biotechnology
Vivan and Ad Atomica pair tumor genotype data with AI drug design
16 September 2026
Pharmaceutical
ICER releases evidence report on treatment for Parkinson’s disease
16 September 2026
Pharmaceutical
Remepy welcomes new CMO to advance hybrid drug pipeline
16 September 2026
Pharmaceutical
Sling Therapeutics announces $123M financing
16 September 2026
Pharmaceutical
Top-20 Novartis shareholder demands board shake-up after back-to-back trial failures
16 September 2026
Pharmaceutical
FDA unveils expedited IND pilot, begins accepting applications
16 September 2026
Biotechnology
Lundbeck wins Japanese approval for Vyepti
16 September 2026




Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze